| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
9,885 |
8,580 |
$533K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,178 |
2,982 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,569 |
2,401 |
$19K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,183 |
1,155 |
$3K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
186 |
185 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
73 |
73 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
121 |
111 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
316 |
313 |
$1K |
| 90686 |
|
273 |
272 |
$1K |
| 99000 |
|
165 |
160 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
65 |
64 |
$722.17 |
| 36415 |
Collection of venous blood by venipuncture |
521 |
446 |
$493.57 |
| 90670 |
|
12 |
12 |
$230.14 |
| 90656 |
|
14 |
14 |
$144.10 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
64 |
31 |
$109.68 |
| 87428 |
|
27 |
26 |
$76.86 |
| 96127 |
|
63 |
63 |
$46.52 |
| 87807 |
|
13 |
13 |
$21.70 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$19.42 |
| 3078F |
|
3,558 |
3,373 |
$0.00 |
| 1033F |
|
782 |
728 |
$0.00 |
| 1159F |
|
5,725 |
5,273 |
$0.00 |
| 99173 |
|
58 |
58 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
92 |
92 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
27 |
$0.00 |
| 1032F |
|
25 |
24 |
$0.00 |
| 90685 |
|
12 |
12 |
$0.00 |
| 3079F |
|
1,524 |
1,468 |
$0.00 |
| 1036F |
|
1,929 |
1,805 |
$0.00 |
| 3075F |
|
110 |
110 |
$0.00 |
| 3074F |
|
4,555 |
4,286 |
$0.00 |
| 2000F |
|
4,273 |
4,008 |
$0.00 |
| 2010F |
|
4,852 |
4,565 |
$0.00 |
| 3048F |
|
194 |
185 |
$0.00 |
| 1034F |
|
324 |
302 |
$0.00 |
| 3008F |
|
13 |
12 |
$0.00 |
| 1220F |
|
214 |
210 |
$0.00 |
| 3049F |
|
68 |
64 |
$0.00 |
| 4037F |
|
20 |
20 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
14 |
13 |
$0.00 |
| 2001F |
|
15 |
14 |
$0.00 |
| 3044F |
|
13 |
12 |
$0.00 |
| 3017F |
|
15 |
12 |
$0.00 |